Discontinuation report ATROVENT NASAL SPRAY
| Report ID | 64496 |
| Drug Identification Number | 02163713 |
| Brand name | ATROVENT NASAL SPRAY |
| Common or Proper name | ATROVENT Nasal Spray 0.06%, 165 doses - 42 mcg |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | IPRATROPIUM BROMIDE |
| Strength(s) | 42MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | NASAL |
| Packaging size | 15ML |
| ATC code | R01AX |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-10-31 |
| Actual discontinuation date | 2018-11-13 |
| Remaining supply date | 2018-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-07-27 | French | Compare |
| v5 | 2020-07-27 | English | Compare |
| v4 | 2018-10-17 | French | Compare |
| v3 | 2018-10-17 | English | Compare |
| v2 | 2018-10-17 | French | Compare |
| v1 | 2018-10-17 | English | Compare |
Showing 1 to 6 of 6